Antibodies Do NOT Produce Immunity

 

Antibodies do not produce immunity. 

The immune system consists of at least two parts which are the humoral and the cellular. When one is activated the other is suppressed. Because of this, the new approach has been to try and prevent suppression.

 

Dr. Rebecca Carly explains:

The mechanism by which the immune system is corrupted can best be realized when you understand that the two poles of the immune system (the cellular and humoral mechanisms) have a reciprocal relationship in that when the activity of one pole is increased, the other must decrease. Thus, when one is stimulated, the other is inhibited.  Since vaccines activate the B cells to secrete antibody, the cytotoxic (killer) T cells are subsequently suppressed.  (In fact, progressive vaccinia (following vaccination with smallpox) occurs in the presence of high titers of circulating antibody to the virus1 combined with suppressed cytotoxic T cells, leading to spreading of lesions all over the body).  This suppression of the cell mediated response is thus a key factor in the development of cancer and life threatening infections.  In fact, the “prevention” of a disease via vaccination is, in reality, an inability to expel organisms due to the suppression of the cell-mediated response.  Thus, rather than preventing disease, the disease is actually prevented from ever being resolved.  The organisms continue circulating through the body, adapting to the hostile environment by transforming into other organisms depending on acidity, toxicity and other changes to the internal terrain of the body as demonstrated by the works of Professor Antoine Béchamp.  He established this prior to the development of the “germ theory” of disease by Louis Pasteur.  Pasteur’s “germ theory” was a plagiarist’s attempt to reshape the truth from Béchamp into his own “original” premise – the beLIEf that germs are out to “attack” us, thereby causing dis-ease. Thus, treatment of infection with antibiotics as well as “prevention” of disease with vaccines are both just corrupted attempts at cutting off the branches of dis-ease, when the root of the cause is a toxic internal environment combined with nutritional deficiency.  However, since Pasteur’s germ theory was conducive to the profits of the burgeoning pharmaceutical cartels that only manage dis-ease, no mention of the work of Professor Béchamp is made in medical school curricula.

     To make matters worse than the suppression of cellular immunity which occurs when vaccines are injected, adjuvants (which are substances added to vaccines to enhance the antibody response) can actually lead to serious side effects themselves. Adjuvants include oil emulsions, mineral compounds (which may contain the toxic metal aluminum), bacterial products, liposomes (which allow delayed release of substances), and squalene.  The side effects of adjuvants themselves include hyperactivity of B cells leading to pathologic2 levels of antibody production,  as well as allergic reaction to the adjuvants themselves (as demonstrated in Gulf War I soldiers injected with vaccines containing the adjuvant squalene, to which antibodies were found in many soldiers). Note that the pathologically elevated hyperactivity of antibody production caused by adjuvants also results in a distraction from the other antigens that the immune system encounters “naturally”, which must be addressed to maintain health.

 

Antibodies

 

When a B lymphocyte encounters an antigen, it is stimulated to mature into a plasma cell, which then produces antibodies (also called immunoglobulins, or Ig). Antibodies protect the body by helping other immune cells ingest antigens, by inactivating toxic substances produced by bacteria, and by attacking bacteria and viruses directly. Antibodies also activate the complement system. Antibodies are essential for fighting off certain types of bacterial infections.

Each antibody molecule has two parts. One part varies; it is specialized to attach to a specific antigen. The other part is one of five structures, which determines the antibody’s class-IgG, IgM, IgD, IgE, or IgA. This part is the same within each class.

IgM: This class of antibody is produced when a particular antigen is encountered for the first time. The response triggered by the first encounter with an antigen is called the primary antibody response. Normally, IgM is present in the bloodstream but not in the tissues.

IgG: The most prevalent class of antibody, IgG is produced when a particular antigen is encountered again. This response is called the secondary antibody response. It is faster and results in more antibodies than the primary antibody response. IgG is present in the bloodstream and tissues. It is the only class of antibody that crosses the placenta from mother to fetus. The mother’s IgG protects the fetus and infant until the infant’s immune system can produce its own antibodies.

IgA: These antibodies help defend against the invasion of microorganisms through body surfaces lined with a mucous membrane, including those of the nose, eyes, lungs, and digestive tract. IgA is present in the bloodstream, in secretions produced by mucous membranes, and in breast milk.

IgE: These antibodies trigger immediate allergic reactions (see Allergic Reactions: Introduction). IgE binds to basophils (a type of white blood cell) in the bloodstream and mast cells in tissues. When basophils or mast cells with IgE bound to them encounter allergens (antigens that cause allergic reactions), they release substances that cause inflammation and damage surrounding tissues. Thus, IgE is the only class of antibody that often seems to do more harm than good. However, IgE may help defend against certain parasitic infections that are common in some developing countries.

IgD: Small amounts of these antibodies are present in the bloodstream. The function of IgD is not well understood.

An Introduction to Immunity

 

INNATE IMMUNITY = This can best be described as GENETIC IMMUNITY or that immunity an organism is BORN WITH. This type of immunity can be an immunity that applies to the vast majority of the members of a species (SPECIES IMMUNITY), or it can be an immunity that applies to only a certain subgroup within a species down to a few individuals within that species. For example, cattle suffer from the cowpox virus, but appear to have a SPECIES IMMUNITY to the closely related smallpox viruses, whereas smallpox is a deadly disease to humans , but cowpox is a mild localized skin infection. Humans are susceptible to the HIV virus, but most of our related primates are immune to HIV, but they suffer from HIV-like viruses to which we appear to be immune. Within a species there may exist SUBGROUPS that are STATISTICALLY immune or resistant to particular pathogens. For example, the Northern Europeans appears to be more resistant to tuberculosis than are most Africans, whereas Africans are naturally resistant to a variety of African diseases that readily kill the “whites”. Finally, because of the genetic variation within every species INDIVIDUALS are statistically more resistant to some diseases, and more susceptible to other diseases. Most of you know those within your own families that “rarely” get colds or the flu, while other family members catch one respiratory infection after another. While there are many factors (diet, stress etc.) that could explain these individual differences, one of them is that certain COMBINATIONS OF GENES render some more resistant to the common cold viruses, whereas others of us are very susceptible. This type of immunity has NOTHING TO DO WITH the type of specific immunity we are discussing in this section.

ACQUIRED IMMUNITY = This refers to immunity that one acquires in one of two ways, active or passive. These are subdivided into the following further categories:

a) ACTIVE NATURALLY ACQUIRED IMMUNITY = This occurs when individuals suffer from
    a natural infection of a pathogen and become immune to that pathogen upon recovery (e.g.
    chickenpox)
b) ACTIVE ARTIFICIALLY ACQUIRED IMMUNITY = This occurs when individuals are
    actively vaccinated with an antigen that confers immunity.

c) PASSIVE NATURALLY ACQUIRED IMMUNITY = This occurs when individuals receive
    antibodies from their mother by a natural process, such as in BREAST MILK or in-utero transfer of
    antibodies from mother to fetus. In mammals, mother’s milk is know to contain a large concentration
    of antibodies and other antiviral and antibacterial substance that protect the newborn infants. Further,
    the mother’s antibodies cross the placental barrier, particularly near the end of term. In both these
    circumstances the infant is only resistant to whatever the mother is resistant to.
d) PASSIVE ARTIFICIALLY ACQUIRED IMMUNITY = This occurs when individuals are
    injected with POOLED serum from immune individuals that contain antibodies against a large number
    of pathogens. In the case of humans, a fraction of blood serum, GAMMA GLOBULIN, that is
    highly enriched in antibodies is injected into individuals that have been exposed to certain pathogens.
    The GAMMA GLOBULIN is obtained from pooled sera from many individuals and thus contains a
    broad spectrum of antibodies.

 

LENGTH OF IMMUNITY

PASSIVE acquired immunity is short lived as the antibodies eventually die off or are themselves removed from the body as foreign protein. Since the person receiving the passive dose DOES NOT PRODUCE their own antibodies, the immunity is TRANSIENT.

The ACTIVE forms of immunity are generally long lived, particularly in the case of recovery from a CLINICAL INFECTION. Sometimes this immunity it lifelong, but in other cases it is not. Vaccinations may induce long-lived immunity, but recent data indicate that vaccinations may not last as long as once was hoped. For example, there is a very effective vaccine against tetanus, but it lasts only a few years and every year hundreds of people who have been vaccinated against this bacterium die because they have not gotten their BOOSTER SHOTS (vaccinations given periodically to booster the immunity of previous vaccinations) every three to five years.

 

Vaccines and the immune response to vaccination

  • Live and live-attenuated vaccines Live vaccines contain either low doses or doses of mild forms of the disease organism. Live-attenuated vaccines contain living disease organisms that have been treated in some way to reduce their ability to cause disease while still causing an immune response. Both of these vaccines contain living organisms that are able to infect and multiply in the host and this enhances the strength and duration of the immune response.

 

  • Killed (or inactivated) vaccines Killed contain high doses of the killed disease organism. Killed vaccines generally result in a weaker and shorter immune response than live vaccines due to their inability to infect and multiply in the host.

 

  • Sub-unit vaccines These vaccines contain doses of purified antigens extracted from the disease organism.

 

  • Recombinant vaccines These vaccines are produced by incorporating the DNA for the antigens that stimulate a disease response to a disease organism into a vector (or carrier), such as a harmless virus, which is then used as a live vaccine.

 

  • DNA vaccines These vaccines contain purified DNA for the antigens that stimulate an immune response to a disease organism.

 

  • Conjugate vaccines These vaccines are used to elicit an immune response to an antigen that is normally able to evade detection by the immune system. They contain the antigen bound to a compound, such as a protein, to form a complex that is detectable by the immune system.

 

Antibody titers and immunity: Are they related?

Dr. Tedd Koren, D.C. stated, “Whenever we read vaccine papers, the MD researchers always assume that if there are high antibody levels after vaccination, then there is immunity (immunogencity). But are antibody levels and immunity the same? No! Antibody levels are not the same as IMMUNITY. The recent MUMPS vaccine fiasco in Switzerland has re-emphasized this point. Three mumps vaccines-Rubini, Jeryl-Lynn and Urabe (the one withdrawn because it caused encephalitis)- all produced excellent antibody levels but those vaccinated with the Rubini strain had the same attack rate as those not vaccinated at all, there were some who said that it actually caused outbreaks.” [Ref: Schegal M et al Comparative efficacy of three mumps vaccines during disease outbreak in Switzerland: cohort study. BMJ, 1999; 319:352-3.]

According to Trevor Gunn, B.Sc., “Many measles vaccine efficacy studies relate to their ability to stimulate an antibody response, (sero-conversion or sero-response). An antibody response does not necessarily equate to immunity….the level of antibody needed for effective immunity is different in each individual….immunity can be demonstrated in individuals with a low or no detectable levels of antibody. Similarly in other individuals with higher levels of antibody there may be no immunity. We therefore need to stay clear on the issue: How do we know if the vaccine is effective for a particular individual when we do not know what level of antibody production equals immunity?”

Dr. John March, a developer of animal vaccines, wrote, “Particularly for viral diseases, the ‘cellular’immune response is all important, and antibody levels and protection are totally unconnected.”

It is clear that immunity does not come from antibodies or even ‘memory cells’, although memory cells may play a small part in the much larger processes of protecting health. If a person is healthy, first time natural exposure to a virus does not necessarily result in disease. In fact, the majority of first time exposures result in no symptoms but do result in ‘antibodies’ which ‘prove the exposure’ but also prove that immunity was present before the exposure. Total body health is the only true immunity. The concept that immunity comes from ‘memory cells’ is none-the-less valuable in that it points out that booster shots are totally unnecessary. Knowing that total health equals immunity is a basic key to understanding that vaccinations are unnecessary and ineffective.

 

Titers: What do they tell us?

A “titer” is a measurement of how much antibody to a certain virus (or other antigen) is circulating in the blood at that moment. Titers are usually expressed in a ratio, which is how many times they could dilute the blood until they couldn’t find antibodies anymore. So let’s say they could dilute it two times only and then they didn’t find anymore, that would be a titer of 1:2. If they could dilute it a thousand times before they couldn’t find any antibody, then that would be a titer of 1:1000.

A titer test does not and cannot measure immunity, because immunity to specific viruses is reliant not on antibodies, but on memory cells, which we have no way to measure. Memory cells are what prompt the immune system to create antibodies and dispatch them to an infection caused by the virus it “remembers.” Memory cells don’t need “reminders” in the form of re-vaccination to keep producing antibodies.

Vaccine Titer Table

This just doesn’t apply to humans but pets as well.

Advertisements

Types of Vaccines

Inactivated Vaccines

Inactivated vaccines are produced by killing the disease-causing microorganism with chemicals or heat. They cannot revert to the virulent, disease-causing, form. They often do not require refrigeration, which  makes them accessible to virtually everyone.  Inactivated vaccines can stimulate a relatively weak immune response and must be given more than once. Vaccines that require several doses or boosters can have a limited usefulness, especially for people who have limited access to regular health care. The flu shot, polio(ipv) hepatitis A are examples of inactivated vaccines.

Live, Attenuated Vaccines 

A live, attenuated vaccine,  is made by growing the disease-causing organism under special laboratory conditions that cause it to lose its virulence, or disease-causing attributes. Live vaccines require special handling and storage in order to maintain their potency. They produce antibody-mediated and cell-mediated immunity and require only one dose or booster. Most live vaccines are injected with the exception of oral polio (opv), oral Rotavirus (Rotateq), and flumist (flu) which is intranasal ( administered in the nose). The injected live vaccines are all components of the MMR( Measles, Mumps, Rubella), Chickenpox(Varicella), Shingles(Zostavax), and smallpox.
Live vaccines do have drawbacks. They can mutate and there is the possibility that the organism may revert to a virulent form and cause disease. People with compromised immune systems should not given live vaccines nor be around those who have recently received them due to possible vaccine shedding

 
Toxoids

A toxoid  is an inactivated toxin, which is a harmful substance produced by a microbe. Many microbes that infect people are not harmful. It is the toxins they produce that can cause illness. Tetanus is an example of this. The bacterium that causes tetanus can be found everywhere around us, but with plenty of oxygen, it is harmless. If, however, it is put into an environment without oxygen,  the organism changes and produces tetanus toxin. To inactivate such the toxins, the vaccines are treated with materials that cripple their disease-causing ability. Formalin, is often used to inactivate toxins and produce toxoids. Toxoid vaccines are used against tetanus and diphtheria.

 

Conjugate Vaccines 

For  conjugate vaccines, proteins or toxins from a second type of organism, one that an immature immune system can recognize, are linked to the outer coats of the disease-causing bacteria. This enables a young immune system to respond and defend against the disease agent.  The creation of an effective immunogen is most often used in bacterial polysaccharides for the prevention of invasive bacterial disease such as, Haemophilus influenzae type b (Hib), and Meningococcus, and Pneumococcal.

 

Subunit Vaccines

These vaccines contain purified antigens rather than whole organisms. The disadvantages of subunit vaccines are that the antibodies produced against the subunit may not recognize the same protein on the pathogen surface. Therefore, an isolated protein may not stimulate the immune system as well as a whole organism vaccine. The effectiveness of subunit vaccines is increased by adding adjuvants. Alum (aluminum salts) is a common adjuvant used in vaccines. Pertussis toxin, one of the components of the DTaP, acts as an adjuvant in that vaccine.  Subunit vaccines are used to protect against pneumonia caused by Streptococcus pneumoniae and against a type of meningitis.

Recombinant subunit vaccines like hepatitis B  is made by inserting a small portion of the hepatitis B virus’ genetic material into common baker’s yeast. This process induces the yeast to produce an antigen, which is thus purified. The purified antigen is then combined with an adjuvant.

 
Recombinant Vector Vaccines

A vaccine carrier, or vector, is a weakened virus or bacterium  which genetic material from another disease-causing organism can be inserted. The vaccinia virus is used to make recombinant vector vaccines such as smallpox. There are currently no recombinant vector vaccines are licensed for routine use in the United States.

 

DNA Vaccines

These vaccines use both the whole organism and its parts; the microbe’s genetic material. A DNA vaccine against a microbe could evoke a strong antibody response to the free-floating antigen secreted by cells, and would thus stimulate a strong cellular response against the microbial antigens displayed on cell surfaces. The DNA vaccine wouldn’t cause the disease since it doesn’t contain the microbe, just copies of a few of its genes. DNA vaccines being tested are influenza, bird flu, and herpes.

 

Immune Globulins

Immune globulins are made by collecting plasma from people who have contracted or were vaccinated for a particular disease, and their plasma contains protective antibodies, known as IgG.  These antibodies are isolated by fractionation of the plasma, purified and administered intravenously or by intramuscular injection, and thus providing an immediate protective effect. Immune globulins are used to generate an immediate protective immune response.